Načítá se...
Procalcitonin Is a Prognostic Marker of Hospital Outcomes in Patients with Critical Limb Ischemia and Diabetic Foot Infection
AIM: To evaluate the prognostic role of procalcitonin (PCT) in patients with diabetic foot infection (DFI) and critical limb ischemia (CLI). MATERIALS AND METHODS: The study group was composed of diabetic patients with DFI and CLI. All patients were treated according to a preset limb salvage protoco...
Uloženo v:
| Vydáno v: | J Diabetes Res |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6710766/ https://ncbi.nlm.nih.gov/pubmed/31485450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/4312737 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|